Roland W. Herzog

B-cell depletion is protective against anti-AAV capsid immune response: a human subject case study

T. Conlon, N. Clément, M. Corti, 2014, Molecular therapy. Methods & clinical development.

Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV-hGAA) Gene Therapy in Children Affected by Pompe Disease.

T. Conlon, B. Byrne, I. Tuna, 2017, Human gene therapy. Clinical development.

Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies

C. Tifft, M. Corti, Precilla D’Souza, 2023, The Journal of clinical investigation.

B cell focused transient immune suppression protocol for efficient AAV readministration to the liver

M. Corti, D. Markusic, Moanaro Biswas, 2024, Molecular therapy. Methods & clinical development.

Innate Immune Sensing of AAV Vectors.

Ype de Yong, Roland W. Herzog, C. Terhorst, 2024, Human gene therapy.